Marcos López-Hoyos to Treatment Outcome
This is a "connection" page, showing publications Marcos López-Hoyos has written about Treatment Outcome.
Connection Strength
0.015
-
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):472.
Score: 0.008
-
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study. Schizophr Res. 2018 12; 202:226-233.
Score: 0.007